| Publication Title |
The Issue |
The Author |
| Keeping Tags on Biomolecules |
Manufacturing Chemist, April 2012 |
Sean Kitson of Almac |
| The Emergence of Strategic Outsourcing in Clinical Supply Chain Managment |
PharmaVoice |
Robert Dunlop, President and Managing Director of Almac Clinical Services & Jim Murphy, President and Managing Director of Almac Clinical Technologies |
| Accelerating Chemical Development and Minimising cost for fine chemical / API manufacture and metabolite synthesis |
Pharma Sep / Oct 2011 |
Tom Moody of Almac |
| Synthesis of isotopically labelled [14C]ZT-1(Debio-9902), [d3]ZT-1 and (-)-[d3]huperzine a new generation of acetylcholinesterase inhibitors |
Journal of Labelled Compounds and Radiopharmaceuticals |
Loïc Leman, Sean L Kitson, Rodney T Brown, Jana Cairns, William Watters, Austin McMordie, Victor L Murrell, and Judith Marfurtb |
| Personalised medicine from concept to clinical use |
sp2 July/August 2011 |
Austin Tanney and Peter Kerr of Almac |
| Almac takes a clinical approach – Almac CEO Alan Armstrong talks about the firm’s continuing expansion |
Ulster Business (Northern Ireland's Top 100 Companies) |
Symon Ross |
| A Facile Stereoselective Biocatalytic Route to the Precursor of Woody Acetate |
Organic Process & Development (ACS Publications) |
Moody, T.S., et al; OPRD, 2011 |
| Addressing the Patient Factor in ePRO to Improve Compliance |
Journal for Patient Compliance |
Jennifer Ross & Hannah O'Gorman (Clinical Technologies) |
| The clinic is open – The Almac Group officially unveiled its North American HQ |
Speciality Chemicals July 2011 |
Andrew Warmington |
| Packaging Design – In the Details |
PMPS, 2011 |
Jane Donaghey (Almac Pharma Services) |
| Example of Almac’s array work with the University of Miami as published in Oncology Times |
Oncology Times - June 2011 |
Robert H Carlson |
| The High Tide of Cancer Research in Europe |
The Oncologist; May 2010; 16: 539-542; doi:10.1634/theoncologist.2011-0119 |
Patrick G. Johnston and H.M. Pinedo |
| CROs and the Clinical Supply Chain – It’s not just a label on a box |
Almac |
Barry Carthcart, BDM (Almac Clinical Services) |
| Biocatalysis: the key to successful chiral synthesis |
SP2 January/February 2011 |
Tom Moody, PhD Head of Biocatalysis and Denis Geffroy, VP of Business Development (Almac Sciences) |
| Lipase catalysed kinetic resolutions of 3-aryl alkanoic acids |
Tetrahedron Asymmetry, 22, 47, 2011 |
Moody, Tom, et al |
| Enantiopure Chiral Alcohol Libraries from carbonyl reductases |
UK Technology Strategy Board-Funded Project with Almac Sciences |
R Howard, I Miskelly, T Moody, A Rowan & T Underwood |
| Encapsulating Quality |
Spotlight feature in PMPS |
Colin Lorimer, Senior Formulation Scientist |
| Fluorescence Lifetime finally picking up momentum! |
Drug Discovery World Summer 2010 |
Dr John Comley |
| Efficient kinetic bioresolution of 2-nitrocyclohexanol |
Tetrahedron: Asymmetry |
Moody T, et al (Almac Sciences) |
| Electronic Patient Reported Outcomes The Future of Patient Centred Data in Global Clinical Trials |
JCS July 2010 |
J Bedford (Almac Clinical Technologies) |
| Why are Solid Forms Still Causing Headaches? |
Innovations in Pharmaceutical Technology - Jun 2010 |
N Hamill (Almac Sciences) |
| Accelerated Radiochemistry |
PMPS May 2010 |
S Kitson (Almac Sciences) |
| N-Boc 4-nitropiperidine: preparation and conversion into a spiropiperidine analogue of the eastern part of maraviroc |
Tetrahedron Letters |
P Mullen, H Miel, M. Anthony McKervey |
| Greener, sustainable processes using efficient biocatalyst purification tools at Almac Sciences |
PharmChem March/April 2010 |
Tom Shaw Moody |
| Developing mRNA-based biomarkers from formalin-fixed paraffin-embedded tissue |
Personalized Medicine, Mar 2010, Vol. 7, No. 2, Pages 205-211 |
A Tanney, R D Kennedy (Almac Diagnostics) |
| Genomic Markers for Decision Making |
Nature - Feb 2010 |
P Johnston (Almac Diagnostics) |
| Clinical Applications of Positron Emission Tomography (PET) Imaging in Medicine: Oncology, Brain Diseases and Cardiology |
Current Radiopharmaceuticals (2009) |
S Kitson (Almac Sciences) |
| Highly stereoselective biocatalytic reduction of alpha-halo ketones |
Tetrahedron: Asymmetry |
Moody, T, et al (Almac Sciences) |
| Simple one-pot process for the bioresolution of tertiary amino ester protic ionic liquids using subtilisin |
Tetrahedron: Asymmetry |
Moody T, et al (Almac Sciences) |
| Fluorescent PET (Photoinduced Electron Transfer) sensors as potent analytical tools |
Analyst 2009 |
Moody, T, et al (Almac Sciences) |
| Rapidd Fire |
Speciality Chemicals - Nov 2009 |
D Geffroy - Sciences |
| Carbon-14 radiosynthesis of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-[4-14C]quinolin-2(1H)-one(XEN-D0401), A novel BK channel activatory |
Labelled Compounds and Radiopharmaceuticals |
S Kitson (Almac Sciences) |
| Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 and its Corresponding Prodrug CA1P |
Journal of natural Products |
A Shirali et al (inc. R Brown, V Murrell & A McMordie (Sciences)) |
| The Role of the Pharmacist in the Clinical Supply Chain |
EPC - Autumn 2009 |
W Phillips (Clinical Services) |
| Breast Cancer DSA Technical Sheet |
Various |
Diagnostics |
| Colorectal Cancer DSA Technical Sheet |
Various |
Diagnostics |
| Prostate Cancer DSA Technical Sheet |
Various |
Diagnostics |
| Ovarian Cancer DSA Technical Sheet |
Various |
Diagnostics |
| Lung Cancer DSA Technical Sheet |
Various |
Diagnostics |
| DNA Microarray profiling of BRCA1 and BRCA2 deficient human tumors and cell-lines using a breast specific platform to identify a biomarker of DNA repair deficiency |
AACR 2009 |
J. M. Mulligan, V. Farztdinov et al |
| Defining multi-ethnic genome-wide transcriptional signatures in normal and cancerous breast tissue using paraffin embedded samples |
AACR 2009 |
Lisa L. Baumbach, Mary Ellen Ahearn et al |
| Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues |
NCRI 2009 |
A Grigoriadis, Gavin Oliver, et al |
| Molecular Subtyping of Colon Cancer |
ASCO 2009 |
R.D. Kennedy, A Winter et al |
| Industry Application – Sample pack boosts Moxatag launch |
Matthew Knopp |
Tablets & Capsules May 2009 |
| Development of an Acid-Washable Tag for the Separation of Enantiomers from Bioresolutions |
American Chemical Society |
Dr T Moody et al (Sciences) |
| The Renaissance in IVR/IWR Systems |
Contract Pharma - Apr 2009 |
J Bedford (Clinical Technologies) |
| Reinvesting in the Future |
Chemistry World - Mar 2009 |
James Mitchell Crow (Chemistry World) |
| Chain Reactions |
ICT - Jan 2009 |
J Calderwood (Clinical Services) |
| Fuelling the Chiral Line with Biocatalysis Power |
Speciality Chemicals Magazine (Jan 2009) |
Dr T Moody & Dr S Taylor (Sciences) |
| Diazocarbonyls: Versatile Intermediates in Chemical Synthesis |
SP2 - Nov 2008 |
T McKervey & H Miel (Sciences) |
| Synthesis of 14C Radio-labelled Combretastatin A-1 diphosphate |
OXiGENE |
Rodney T. Brown (Sciences) |
| Clinical Determinants of Response to Irinotecan-Based Therapy |
Cancer Therapy |
Wendy L. Allen, Vicky M. Coyle et al (Diagnostics) |
| Genetic Differences Between Ethnicities May Determine Breast Cancer Prognosis |
Affymetrix Microarray Bulletin - Summer 08 |
Stacey Ryder - courtesy of Affymetrix |
| Profile: Sir Allen McClay (The Scientist Magazine) |
The Scientist: Life Sciences in Ireland - A New Celtic Culture - Jul 08 |
Karen Lillington |
| Almac Offers a Range of Integrated Services |
GEN News - Jun 08 |
Susan Aldridge |
| Generation of a Non-Small Cell Lung Cancer Transcriptome |
BMC Medical Genomics |
A Tanney et al (Diagnostics) |
| Temperature Controlled Shipping in Clinical Trials: A Rising Requirement |
World Pharma Network |
N Kohner (Clinical Services) |
| Dissecting Adaptive Design |
ACT - May 08 |
E Miller et al (Clinical Technologies) |
| Multi-Ethnic Comparisons of Genome-wide Alterations in Breast Cancer using Paraffin Embedded Samples |
ASHG - Oct 2007 |
Assistant Prof Lisa Baumbach |
| Minding the Gaps |
Chemical and Engineering News - Mar 2008 |
Rick Mullin (C and EN) |
| Full-service Model Supports Pharmaceutical Development |
SP2 - Feb 2008 |
Tom Mulligan (SP2) |
| Almac Targets Formidable Growth |
Chemical Week - Feb 2008 |
Alex Scott (Chemical Week) |
| The Power of Communication |
ICT - Winter 2007 |
M Woolf (Clinical Services) |
| Integrating and Interfacing |
ICT - Autumn 2007 |
J Calderwood (Clinical Services) |
| Logistical Change |
PMPS - Autumn 2007 |
J Gorman (Clinical Services) |
| Clinical Teams and Tools: new Approaches for Smarter Clinical Trials |
ICT (Summer 07) |
E Miller & H Li (Clinical Technologies) |
| Unmasking the Blind of Over-Encapsulation |
PMPS - Spring 2007 |
Richard Shannon (Clinical Services) |
| The Medicine Man – Sir Allen McClay |
Cara Magazine - Aer Lingus Apr/May 07 |
Carissa Casey |
| An integrated approach to the clinical supply chain: – how we must master the links between IVRS systems and trial supplies |
International Clinical Trials - Mar 2007 |
J Calderwood & J Murphy (Clinical Services & Technologies) |
| White Paper – Experimental Design |
Various |
S Moore (Diagnostics) |
| White Paper – Deciphering the Transcriptome |
Varoius |
A Tanney & G Oliver (Diagnostics) |
| New Horizons for Clinical Trials |
PMPS - Jan 2007 |
Dr R Dunlop (Clinical Services) |
| The Clinical Trial Supply Chain: Best Practice to Ensure Effective Management. |
Manufacturing Chemist - Feb 2007 |
J Calderwood (Clinical Services) |
| Chemokines and Chemical Protein Synthesis |
Speciality Chemicals Magazine - Nov 2006 |
Dr G Cotton and D Geffroy (Sciences) |
| Audit in America: An EU Inspector Calls |
GCPj - Aug 2006 |
M Rohlfing (Clinical Services) |
| The Clinical Trial Supply Chain |
PMPS - Spring 2006 |
J Calderwood (CTS) |
| Implementing Probabilistic Baseline Covariate Adaptive Randomizations for Clinical Trials |
Applied Clinical Trials (May 2006) |
E Miller & J Murphy (ICTI) |
| Supplying The Needs of Emerging Markets |
BioPharm Knowledge - April 2006 |
R Shannon (CTS) |
| Implementation of Adaptive Randomisations for Clinical Trials |
CR Focus - March 2006 |
E Miller (ICTI) |
| Intelligent Design |
ICT - Spring 2006 |
E Miller et al (ICTI) |
| Clinical Trial Supply Tracking Using Existing Tools |
GCP - March 2006 |
M Lamb (CTS) |
| Putting a Label on Clinical Trial Success |
PMPS - Winter 2005 |
D McKay (CTS) |
| Keep Your Balance |
Good Clinical Practice Journal |
E Miller (ICTI) |
| Integrating Technologies for Complete Chemical Synthesis |
SP2 - Nov / Dec 2005 |
D Moody (CSS) |
| The Trial of Emerging Markets |
GCP - Nov 2005 |
M Lamb (CTS) |
| Inhalers For Double Blind Clinical Trials |
PMPS - Autumn 2005 |
M Lamb (CTS) |
| Broadening the Custom Synthesis Technology Portfolio |
SP2 - Aug 2005 |
S Barr (CSS) |
| Interview with Dr Allen McClay |
GOR - Summer 2005 |
A McClay (Almac) |
| Implementing and Managing Adaptive Designs for Clinical Trials |
EPC - Summer 2005 |
J Murphy (ICTI) |
| Chiral Technologies |
Chimica Oggi - Apr 2005 |
D Moody (CSS) |
| Improving Patient Compliance in Clinical Trials |
PMPS - Winter 2004 |
M Lamb (CTS) |
| Changes in the Conduct of Clinical Trials in Europe |
GOR - Autumn 2004 |
O McCormick (CTS) |
| The World’s Biggest Chemistry Set |
EPE - Jul/Aug 2004 |
A McClay (Almac) |